Dare Bioscience Inc (DARE)
0.4348
+0.07
(+20.78%)
USD |
NASDAQ |
May 16, 16:00
0.4348
0.00 (0.00%)
After-Hours: 07:25
Dare Bioscience Cash and Short Term Investments (Quarterly): 10.48M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.48M |
| September 30, 2023 | 13.89M |
| June 30, 2023 | 13.33M |
| March 31, 2023 | 19.83M |
| December 31, 2022 | 34.67M |
| September 30, 2022 | 40.39M |
| June 30, 2022 | 32.07M |
| March 31, 2022 | 39.32M |
| December 31, 2021 | 51.67M |
| September 30, 2021 | 45.57M |
| June 30, 2021 | 9.112M |
| March 31, 2021 | 7.660M |
| December 31, 2020 | 4.670M |
| September 30, 2020 | 5.389M |
| June 30, 2020 | 5.347M |
| March 31, 2020 | 5.047M |
| December 31, 2019 | 4.780M |
| September 30, 2019 | 2.435M |
| June 30, 2019 | 5.631M |
| March 31, 2019 | 3.505M |
| December 31, 2018 | 6.806M |
| Date | Value |
|---|---|
| September 30, 2018 | 9.538M |
| June 30, 2018 | 12.45M |
| March 31, 2018 | 15.62M |
| December 31, 2017 | 7.560M |
| September 30, 2017 | 8.529M |
| June 30, 2017 | 7.244M |
| March 31, 2017 | 12.03M |
| December 31, 2016 | 0.0446M |
| September 30, 2016 | 38.06M |
| June 30, 2016 | 47.19M |
| March 31, 2016 | 60.52M |
| December 31, 2015 | 75.91M |
| September 30, 2015 | 77.63M |
| June 30, 2015 | 85.48M |
| March 31, 2015 | 56.32M |
| December 31, 2014 | 51.17M |
| September 30, 2014 | 57.79M |
| June 30, 2014 | 64.27M |
| March 31, 2014 | 8.468M |
| December 31, 2013 | 5.488M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.435M
Minimum
Sep 2019
51.67M
Maximum
Dec 2021
18.49M
Average
10.48M
Median
Dec 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Altimmune Inc | 182.02M |
| Verastem Inc | 110.12M |
| Oragenics Inc | 3.484M |
| Actinium Pharmaceuticals Inc | 84.06M |
| Orgenesis Inc | 0.837M |